CONCN

AcronymDefinition
CONCNConcentration
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The additives were ethylenediamine (CH2NH2)2 (0.01mol/l Concn.) and cyclodextrin (0.01mol/l Concn.) respectively.
Phenytoin equivalent, mg/L (and cross-reactivity (a,b), %) TDx TDx-II Fosphenytoin concn., mg/L A B A B 0.0 ND 12.4 ND 12.5 13.0 5.5 (42) 22.2 (75) 33.0 (254) > 20.0 7.5 (38) 26.6 (71) > > 26.0 9.2 (35) 30.1 (68) > > 39.0 13.0 (33) 35.4 (59) > > 52.0 16.4 (32) > > > AxSym-II ACS:180 Fosphenytoin concn., mg/L A B A B 0.0 ND 12.1 ND 12.4 13.0 3.8 (29) 22.2 (78) 6.5 (50) 19.0 (51) 20.0 4.8 (24) 26.8 (74) 9.8 (49) 22.4 (50) 26.0 5.3 (20) 28.5 (63) 12.5 (48) 25.6 (51) 39.0 NA NA 20.0 (51) 32.0 (50) 52.0 6.7 (17) 27.6 (30) 27.3 (52) > (a) Cross-reactivity (%) in absence of phenytoin (pool A) = 100 x (apparent phenytoin concentration observed)/(fosphenytoin concentration in sample).
Concn., [micro]g/L Sample Endogenous Added Expected Observed recovery 1 0.48 13.05 13.58 12.12 89.20 32.62 33.11 28.53 86.10 65.25 35.73 54.74 92.60 2 0.30 13.05 13.35 13.07 97.90 32.62 32.92 27.07 83.10 65.25 65.55 66.99 102.20 3 1.94 13.05 14.99 16.57 110.50 32.62 34.57 36.39 105.20 65.25 67.19 70.45 104.80 Table 3.
Melatonin concn, ng/L Expected Measured by RIA (added) (mean [+ or -] SD) Calculated (a) Recovery, % Pool 1 0 <1 -- -- 25 <1 -- -- 100 10.7 [+ or -] 7.8 10.73 10.73 400 78.3 [+ or -] 6.4 78.25 19.56 Pool 2 0 <1 -- -- 25 20.2 [+ or -] 1.6 20.17 80.68 100 87.8 [+ or -] 7.0 87.75 87.75 400 317.2 [+ or 0] 21.2 317.22 79.31 Pool 3 0 <1 -- -- 25 5.8 [+ or -] 1.6 5.83 23.32 100 35 [+ or -] 3.1 34.81 34.81 400 154 [+ or -] 21.7 153.94 38.49 Pool 4 0 31.4 [+ or -] 5.0 -- -- 50 129.8 [+ or -] 15.9 98.37 196.74 250 630.0 [+ or -] 62.7 598.62 239.45 425 >750 >718.62 >169.09 (a) Measured concentration minus RIA result for zero added melatonin.
Concn. ([micro]mol/L) of Average compounds added to plasma samples recovery, % Cv, SAH,7.5-30 101 9.40 HCy, (a) 7.5-30 92 14 HCy,(b) 10-40 100 9.5 (a) Added as crystalline L-homocystine.
Serum concn cutoff, mg/L (a) TPC Theophylline, 20 Phenytoin, 22 Positive predictive value (b) 0.43 0.2 Negative predictive value (c) 0.96 0.83 Likelihood ratio positive (d) 5.6 1.4 Likelihood ratio negative (e) 0.4 0.9 Ratio of net consequences (f) 0.27 0.5 (a) Value used as a separator for classifying patients as toxic or nontoxic.
Progesterone concn., [micro]g/L Expected 5- n 95 percentiles Observed range Normal menstruating women Follicular phase 30 0.4-0.9 0.3-2.6 Luteal phase 30 7.8-27.0 3.3-38.6 Mid-Luteal phase 30 9.5-27.3 5.3-38.6 Postmenopausal women 30 0.2-0.5 0.2-0.8 Pregnant women First trimester 25 12.3-81.8 12.3-81.8 Second trimester 25 19.6-77.0 11.1-81.4 Third trimester 25 63.8-246.4 39.3-387.8 Men 77 0.1-1.3 0.1-3.4 Table 3.
At various 7[alpha]-Bio-T concentrations and at the optimum antibody dilution, the ratios of %B (7[alpha]-Bio-T concn >0) to %B (7[alpha]-Bio-T concn = 0) are then calculated and plotted against the tracer concentration.
Hours of storage 0 24 Mucin concn., Plain Gel Plain Gel IU/mL CA 19.9 116 118 118 123 (a,c) CA 125 63 64 67 68 (a) CA 15.3 49.8 50.5 50.4 51.8 (a,c) Hours of storage 48 72 Mucin concn., Plain Gel Plain Gel IU/mL CA 19.9 120 (a) 133 (b,c) 122 (a) 143 (b,d) CA 125 66 (a) 73 (a,c) 68 (a) 776 (b,c) CA 15.3 51.4 (a) 57.4 (b,c) 51.5 (a) 59.8 (b,d) (a,b) Significantly different ((a) P <0.05, (b) P <0.01) from basal values.